FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2022/03/040821 [Registered on: 04/03/2022] Trial Registered Prospectively
Last Modified On: 24/02/2022
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Surgical/Anesthesia 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   A clinical trial to compare the effects of giving lignocaine by intravenous or nebulization to reduce the pressor responses during endotracheal intubation and laryngoscopy.  
Scientific Title of Study   Comparison of efficacy of nebulized lignocaine with intravenous lignocaine for attenuation of pressor response to laryngoscopy and intubation. 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  K T Sreekanth Balagopal 
Designation  Postgraduate resident in Anaesthesiology 
Affiliation  B.J medical college and Civil hospital ,Ahmedabad 
Address  F3,1st floor, department of anaesthesia, B.J medical college, Civil hospital,Asarwa, Ahmedabad-380016 Gujarat

Ahmadabad
GUJARAT
380016
India 
Phone  7975936468  
Fax    
Email  sbkonnnath@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Smita R Engineer 
Designation  Professor 
Affiliation  B.J medical College, Civil Hospital, Ahmedabad 
Address  F3,1st floor, department of anaesthesia, B.J medical college, Civil hospital,Asarwa, Ahmedabad-380016 Gujarat

Ahmadabad
GUJARAT
380016
India 
Phone  9825504948  
Fax    
Email  seng_90@yahoo.com  
 
Details of Contact Person
Public Query
 
Name  Dr Smita R Engineer 
Designation  Professor 
Affiliation  B.J medical College, Civil Hospital, Ahmedabad 
Address  F3,1st floor, department of anaesthesia, B.J medical college, Civil hospital,Asarwa, Ahmedabad-380016 Gujarat

Ahmadabad
GUJARAT
380016
India 
Phone  9825504948  
Fax    
Email  seng_90@yahoo.com  
 
Source of Monetary or Material Support  
BJ medical college,Civil hospital,Government of Gujarat 
 
Primary Sponsor  
Name  Government of Gujarat 
Address  7th floor, Health and family welfare department, Sachivalay ,Gandhinagar 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr K T Sreekanth Balagopal  General Surgery operation theatres  Major surgery Operation theatre, General surgery department, 5th floor, Trauma building, Civil hospital, Ahmedabad, Gujarat
Ahmadabad
GUJARAT 
7975936468

sbkonnanath@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional ethical committee, B.J medical college and Civil hospital, Ahmedabad  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: O||Medical and Surgical,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Intravenous 1.5mg/kg lignocaine bolus and nebulized lignocaine-2% for 20 minutes.  Comparison of efficacy of nebulized lignocaine 2% for 20minutes with intravenous lignocaine 1.5mg/kg bolus for attenuation of pressor response to laryngoscopy and intubation. 
Comparator Agent  Lignocaine by either intravenous 1.5mg/kg bolius or 2% by nebulization route for 20 minutes.  Comparison of efficacy of 2% nebulized lignocaine for 20 minutes with intravenous lignocaine 1.5mg/kg bolus for attenuation of pressor response to laryngoscopy and intubation. 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  63.00 Year(s)
Gender  Both 
Details  ASA 1 and 2 patients posted for surgery under general anaesthesia requiring endotracheal intubation.
 
 
ExclusionCriteria 
Details  Patients with pre existing hypertension, Patients with known allergy to the study drug or contraindication to any of the administered drugs, Patients with anticipated difficult airway, Patients who refused or inability to understand the procedure.
5. Patients who are smokers
6. Patients with History of respiratory distress
7. Patients with gastroesophageal reflux,Neurological ,cardiovascular,respiratory ,hepatic or renal dise
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant Blinded 
Primary Outcome  
Outcome  TimePoints 
Evaluation of efficacy of the NL as compared to IVL in suppressing pressor response to laryngoscopy and intubation
 
Starting of nebulized lignocaine/Intravenous lignocaine to 20th minute after endotracheal intubation. 
 
Secondary Outcome  
Outcome  TimePoints 
Evaluation of efficacy of the 2% lignocaine nebulization for 20minutes as compared to 1.5mg/kg intravenous lignocaine bolus in
suppression of arrhythmias/any other complications if any during laryngoscopy and intubation.

 
Preoperatively before induction starting of 2% nebulized lignocaine/1.5mg/kg Intravenous lignocaine upto 20 minutes after endotracheal intubation. 
 
Target Sample Size   Total Sample Size="100"
Sample Size from India="100" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 4 
Date of First Enrollment (India)   15/03/2022 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   After completion of study. 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Despite adequate anaesthetic depth, direct laryngoscopy and intubation elicit a significant adreno-sympathetic response. This response, as manifested by increased blood pressure (BP), heart rate (HR), arrythmias etc. Lignocaine given intravenous or topically (nebulization) attenuates pressor responses to laryngoscopy and intubation. Very few studies lignocaine by nebulization has been done to evaluate the effect on pressor responses.

The present study was undertaken to compare the efficacy of intravenous lignocaine 2%versus efficacy of nebulized lignocaine before induction of anaesthesia in attenuating the pressor response to direct laryngoscopy and endotracheal intubation.

 


 
Close